Collective Family Office LLC Sells 550 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Collective Family Office LLC cut its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 58.3% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 394 shares of the healthcare conglomerate’s stock after selling 550 shares during the period. Collective Family Office LLC’s holdings in UnitedHealth Group were worth $206,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. Waycross Partners LLC boosted its holdings in UnitedHealth Group by 2.4% in the fourth quarter. Waycross Partners LLC now owns 27,794 shares of the healthcare conglomerate’s stock worth $14,060,000 after purchasing an additional 658 shares in the last quarter. Sherbrooke Park Advisers LLC bought a new stake in UnitedHealth Group during the fourth quarter valued at about $515,000. Full Sail Capital LLC boosted its holdings in UnitedHealth Group by 2.1% during the fourth quarter. Full Sail Capital LLC now owns 1,612 shares of the healthcare conglomerate’s stock valued at $815,000 after acquiring an additional 33 shares during the period. Soros Fund Management LLC bought a new stake in UnitedHealth Group during the fourth quarter valued at about $39,413,000. Finally, Silvercrest Asset Management Group LLC boosted its holdings in UnitedHealth Group by 47.8% during the fourth quarter. Silvercrest Asset Management Group LLC now owns 38,796 shares of the healthcare conglomerate’s stock valued at $19,625,000 after acquiring an additional 12,550 shares during the period. 87.86% of the stock is currently owned by institutional investors.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, CFO John F. Rex acquired 17,175 shares of UnitedHealth Group stock in a transaction on Friday, May 16th. The shares were purchased at an average cost of $291.12 per share, with a total value of $4,999,986.00. Following the completion of the purchase, the chief financial officer now owns 203,796 shares in the company, valued at $59,329,091.52. The trade was a 9.20% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Stephen J. Hemsley acquired 86,700 shares of UnitedHealth Group stock in a transaction on Friday, May 16th. The stock was acquired at an average cost of $288.57 per share, for a total transaction of $25,019,019.00. Following the completion of the purchase, the chief executive officer now owns 679,493 shares of the company’s stock, valued at approximately $196,081,295.01. The trade was a 14.63% increase in their position. The disclosure for this purchase can be found here. Insiders purchased a total of 109,408 shares of company stock valued at $31,607,768 over the last quarter. Corporate insiders own 0.33% of the company’s stock.

Analyst Ratings Changes

UNH has been the subject of several research reports. Mizuho reduced their target price on shares of UnitedHealth Group from $515.00 to $350.00 and set an “outperform” rating for the company in a research note on Friday, May 16th. HSBC reiterated a “reduce” rating and issued a $270.00 target price (down previously from $490.00) on shares of UnitedHealth Group in a research note on Wednesday, May 21st. Hsbc Global Res cut shares of UnitedHealth Group from a “hold” rating to a “moderate sell” rating in a research note on Wednesday, May 21st. Wolfe Research reduced their target price on shares of UnitedHealth Group from $501.00 to $390.00 and set an “outperform” rating for the company in a research note on Tuesday, May 20th. Finally, Barclays reduced their target price on shares of UnitedHealth Group from $513.00 to $362.00 and set an “overweight” rating for the company in a research note on Thursday, May 15th. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating, seventeen have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $441.87.

UnitedHealth Group Stock Performance

NYSE UNH opened at $298.11 on Friday. The firm has a market cap of $270.42 billion, a price-to-earnings ratio of 19.23, a PEG ratio of 1.37 and a beta of 0.56. The company has a 50 day moving average of $435.12 and a 200-day moving average of $496.39. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 1-year low of $248.88 and a 1-year high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). The company had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same period in the prior year, the business earned $6.91 EPS. On average, equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.